Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Apr 11:14:252.
doi: 10.1186/1471-2407-14-252.

Effect of hypoxia on the expression of αB-crystallin in head and neck squamous cell carcinoma

Affiliations

Effect of hypoxia on the expression of αB-crystallin in head and neck squamous cell carcinoma

Chantal van de Schootbrugge et al. BMC Cancer. .

Abstract

Background: The presence of hypoxia in head and neck squamous cell carcinoma (HNSCC) is associated with therapeutic resistance and increased risk of metastasis formation. αB-crystallin (HspB5) is a small heat shock protein, which is also associated with metastasis formation in HNSCC. In this study, we investigated whether αB-crystallin protein expression is increased in hypoxic areas of HNSCC biopsies and analyzed whether hypoxia induces αB-crystallin expression in vitro and in this way may confer hypoxic cell survival.

Methods: In 38 HNSCC biopsies, the overlap between immunohistochemically stained αB-crystallin and pimonidazole-adducts (hypoxiamarker) was determined. Moreover, expression levels of αB-crystallin were analyzed in HNSCC cell lines under hypoxia and reoxygenation conditions and after exposure to reactive oxygen species (ROS) and the ROS scavenger N-acetylcysteine (NAC). siRNA-mediated knockdown was used to determine the influence of αB-crystallin on cell survival under hypoxic conditions.

Results: In all biopsies αB-crystallin was more abundantly present in hypoxic areas than in normoxic areas. Remarkably, hypoxia decreased αB-crystallin mRNA expression in the HNSCC cell lines. Only after reoxygenation, a condition that stimulates ROS formation, αB-crystallin expression was increased. αB-crystallin mRNA levels were also increased by extracellular ROS, and NAC abolished the reoxygenation-induced αB-crystallin upregulation. Moreover, it was found that decreased αB-crystallin levels reduced cell survival under hypoxic conditions.

Conclusions: We provide the first evidence that hypoxia stimulates upregulation of αB-crystallin in HNSCC. This upregulation was not caused by the low oxygen pressure, but more likely by ROS formation. The higher expression of αB-crystallin may lead to prolonged survival of these cells under hypoxic conditions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Immunofluorescent staining of human HNSCC for αB-crystallin, pimonidazole-modified proteins and PAL-E. Shown is a representative biopsy section. The fluorescent grey scale images were binarized, resulting in black and white images for αB-crystallin staining (A) and pimonidazole-modified proteins staining, indicating the hypoxic areas (B). The merged image with αB-crystallin staining (assigned red), pimonidazole staining (assigned green) and PAL-E blood vessel staining (assigned blue) shows a substantial overlap between αB-crystallin and hypoxic regions. Hypoxic regions are mostly located in areas at greater distance from vessels (C).
Figure 2
Figure 2
αB-crystallin expression is increased in hypoxic areas. The symbols represent the relative amount of αB-crystallin staining in the normoxic areas and in the hypoxic areas for each individual HNSCC. Equal staining of αB-crystallin in the normoxic and hypoxic areas would be according to the grey line.
Figure 3
Figure 3
Relative αB-crystallin mRNA expression during hypoxia. αB-crystallin mRNA expression levels in UT-SCC-5 cells after incubation in a humidified 37CH35 hypoxystation at 0.1% O2 for the indicated time points. αB-crystallin mRNA expression levels were assessed via RT-qPCR (N = 4) *** p < 0.001, ** 0.001 < p < 0.01.
Figure 4
Figure 4
Relative αB-crystallin mRNA levels after hypoxia and reoxygenation. αB-crystallin mRNA levels in UT-SCC-5 and UT-SCC-15 cells under 48 hours normoxia (N), hypoxia (H, 0.1% O2) and after reoxygenation (R, 24 hours 0.1% O2/24 hours normoxia). αB-crystallin mRNA expression levels were assessed via RT-qPCR (N = 4). *** p < 0.001, ** 0.001 < p < 0.01, * 0.01 < p < 0.05.
Figure 5
Figure 5
Relative αB-crystallin protein levels after hypoxia and reoxygenation. αB-crystallin protein expression levels in UT-SCC-5 cells under 48 hours normoxia (N), hypoxia (H, 0.1% O2) and after reoxygenation (R, 24 hours 0.1% O2/24 hours normoxia). αB-crystallin protein expression was analyzed of 3–4 independent incubations via western blotting (A) and quantified (B). ***p < 0.001, ** 0.001 < p < 0.01.
Figure 6
Figure 6
Relative αB-crystallin mRNA levels upon H2O2-incubation. Relative αB-crystallin mRNA levels in UT-SCC-5 cells after incubation with 0.0 mM (mock), 0.3 mM, 1.5 mM or 3.0 mM H2O2 for 1 hour and 7 hours of recovery. αB-crystallin mRNA expression levels were assessed via RT-qPCR (N = 4). *** p < 0.001.
Figure 7
Figure 7
Effect of the ROS-scavenger NAC on αB-crystallin mRNA levels during reoxygenation. UT-SCC-5 cells after incubation with mock or NAC under 48 hours normoxia (N), hypoxia (H, 0.1% O2) and after reoxygenation (R, 24 hours 0.1% O2/24 hours normoxia). ** 0.001 < p < 0.01, * 0.01 < p < 0.05.
Figure 8
Figure 8
Knockdown of αB-crystallin expression reduces hypoxia and hypoglycemia survival. Expression of αB-crystallin mRNA in UT-SCC-5 cells was reduced by three different αB-crystallin siRNAs (αB1, αB2 and αB3). LUC and EGFP were used as negative control siRNAs (A). Survival of siRNA-treated UT-SCC-5 cells under normoxic (N) and hypoxic (H, 0.1% O2 for 24 hours) conditions in the presence of 5 mM or 0 mM glucose (B). Cell survival was assessed via a colorimetric assay using cell counting kit-8. The optical density (O.D.) of siEGFP-treated cells was set at 100%. *** p < 0.001, ** 0.001 < p < 0.01, * 0.01 < p < 0.05.

Similar articles

Cited by

References

    1. Harris AL. Hypoxia–a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2:38–47. doi: 10.1038/nrc704. - DOI - PubMed
    1. Liu Y, Song X, Wang X, Wei L, Liu X, Yuan S, Lv L. Effect of chronic intermittent hypoxia on biological behavior and hypoxia-associated gene expression in lung cancer cells. J Cell Biochem. 2010;111:554–563. doi: 10.1002/jcb.22739. - DOI - PubMed
    1. Fukumura D, Duda DG, Munn LL, Jain RK. Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models. Microcirculation. 2010;17:206–225. doi: 10.1111/j.1549-8719.2010.00029.x. - DOI - PMC - PubMed
    1. Mazzone M, Dettori D, Leite De OR, Loges S, Schmidt T, Jonckx B, Tian YM, Lanahan AA, Pollard P, Ruiz De AC, De SF, Vinckier S, Aragones J, Debackere K, Luttun A, Wyns S, Jordan B, Pisacane A, Gallez B, Lampugnani MG, Dejana E, Simons M, Ratcliffe P, Maxwell P, Carmeliet P. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell. 2009;136:839–851. doi: 10.1016/j.cell.2009.01.020. - DOI - PMC - PubMed
    1. Chaudary N, Hill RP. Increased expression of metastasis-related genes in hypoxic cells sorted from cervical and lymph nodal xenograft tumors. Lab Invest. 2009;89:587–596. doi: 10.1038/labinvest.2009.16. - DOI - PubMed

Publication types

MeSH terms